关注
Anita Kuldeep Mehta
Anita Kuldeep Mehta
Dana Farber Cancer Institute
在 dfci.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
C Pantelidou, O Sonzogni, M De Oliveria Taveira, AK Mehta, A Kothari, ...
Cancer discovery 9 (6), 722-737, 2019
5782019
Eukaryotic translation initiation factors in cancer development and progression
R Spilka, C Ernst, AK Mehta, J Haybaeck
Cancer letters 340 (1), 9-21, 2013
1822013
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
AK Mehta, EM Cheney, CA Hartl, C Pantelidou, M Oliwa, JA Castrillon, ...
Nature cancer 2 (1), 66-82, 2021
1762021
Macrophage biology and mechanisms of immune suppression in breast cancer
AK Mehta, S Kadel, MG Townsend, M Oliwa, JL Guerriero
Frontiers in immunology 12, 643771, 2021
1492021
Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia
S Bhatt, MS Pioso, EA Olesinski, B Yilma, JA Ryan, T Mashaka, B Leutz, ...
Cancer cell 38 (6), 872-890. e6, 2020
1232020
Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer
CM Dowling, KER Hollinshead, A Di Grande, J Pritchard, H Zhang, ...
Science Advances 7 (3), eabc4897, 2021
522021
High keratin 8/18 ratio predicts aggressive hepatocellular cancer phenotype
N Golob-Schwarzl, K Bettermann, AK Mehta, SM Kessler, J Unterluggauer, ...
Translational oncology 12 (2), 256-268, 2019
292019
Regulation of autophagy, NF-κB signaling, and cell viability by miR-124 in KRAS mutant mesenchymal-like NSCLC cells
AK Mehta, K Hua, W Whipple, MT Nguyen, CT Liu, J Haybaeck, ...
Science signaling 10 (496), eaam6291, 2017
272017
Keratin 18-deficiency results in steatohepatitis and liver tumors in old mice: A model of steatohepatitis-associated liver carcinogenesis
K Bettermann, AK Mehta, EM Hofer, C Wohlrab, N Golob-Schwarzl, ...
Oncotarget 7 (45), 73309, 2016
252016
RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
J Patterson-Fortin, H Jadhav, C Pantelidou, T Phan, C Grochala, ...
Nature Communications 14 (1), 1390, 2023
222023
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer
JC Lal, MG Townsend, AK Mehta, M Oliwa, E Miller, A Sotayo, E Cheney, ...
Breast Cancer Research 23, 1-24, 2021
162021
MEK and TAK1 regulate apoptosis in colon cancer cells with KRAS-dependent activation of proinflammatory signaling
KL McNew, WJ Whipple, AK Mehta, TJ Grant, L Ray, C Kenny, A Singh
Molecular cancer research 14 (12), 1204-1216, 2016
132016
STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines
TJ Grant, AK Mehta, A Gupta, AAD Sharif, KS Arora, V Deshpande, ...
Oncotarget 8 (45), 78556, 2017
122017
Diagnosis of tuberculosis: the experience at a specialized diagnostic laboratory
A Mashta, P Mishra, S Philipose, S Tamilzhalagan, H Mahmud, S Bhaskar, ...
Journal of Negative Results in BioMedicine 10, 1-7, 2011
62011
Genetic variability, correlation and path coefficient study for various yield and quality traits in NPT lines of rice (Oryza sativa L.).
N Surjaye, Y Singh, SK Singh, S Rahangdale, AK Mehta
32022
Una masa renal poco común en una adolescente–presentación de caso y revisión de la literatura
JSS Galvis, DAC Arévalo, JMS Tovar
Revista Urología Colombiana/Colombian Urology Journal 28 (04), 321-329, 2019
22019
MiR-124 suppresses p62 and p65/NFkB to regulate autophagy, inflammation and cell death in KRAS mutant mesenchymal NSCLC cells
AK Mehta, K Hua, W Whipple, MT Nguyen, RM Perera, J Haybaeck, ...
Cancer Research 77 (13_Supplement), 2524-2524, 2017
22017
A Comparative Study to Evaluate Prognostic Value of Glasgow Coma Score and Full Outline of Unresponsiveness Scale to Predict the Outcome of Unconscious Child in the Paediatric …
A Dwivedi, NK Singh, A Mehta, AK Singh, PK Chaudhary
Journal of Medical Evidence, 2023
12023
821 Immune-mediated mechanisms of PARP inhibitor (PARPi) resistance in BRCA1-associated triple negative breast cancer are overcome by addition of CSF-1R inhibition and immune …
A Nelson, A Mehta, MG Townsend, DE Michaud, M Oliwa, KF Zheng, ...
Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024
2024
825 Targeting lipid metabolism to improve PARP inhibitor response in BRCA-associated TNBC
CWS Wanderley, DE Michaud, K Kurmi, K Shimada, A Nelson, KF Zheng, ...
Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20